Maybe not the biggest name in oncology, as cancer treatment is a very large field, but, perhaps, in a niche, turning non-responders into responders. I've sensed this is the direction Pierce and Punit wish to take OncoSec.
I'm a he Penny and those are Punit's words not mine about being the leader in solid tumor oncology. It's his vision build upon what pierce has unearthed. Maybe you just didn't know the vision of the CEO of the company you are invested in, but obviously he sees and aspires to bigger things than is palatable to you. I'm just glad his nuttiness is running the company and not you're tiny, negative, visionless comments.